| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.17 | $1.65 | $1.70 | $2.43 | $1.79 | $0.53 | $0.47 | $0.56 |
| EPS (Diluted) | $1.17 | $1.65 | $1.70 | $2.42 | $1.78 | $0.54 | $0.47 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.6B | $13.4B | $13.5B | $13.1B | $11.7B | $11.4B | $8.2B | $7.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $12.9B | $11.7B | $11.9B | $11.5B | $10.2B | $10.0B | $7.1B | $6.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.7B | $1.7B | $1.7B | $1.6B | $1.5B | $1.5B | $1.2B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-1.2B | $0.1B | $-0.5B | $-1.3B | $-1.5B | $-0.0B | $-0.2B | $0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.1B | $-0.2B | $0.3B | $1.0B | $0.2B | $1.1B | $0.1B | $-0.1B |